Summary
Overview
Work History
Education
Skills
Languageproficiencies
Personal Information
Awards
Accomplishments
Language Proficiencies
Swiss C Permit
Timeline
Generic

Alejandro Fernandez

Oberrieden

Summary

As an Onco/Hematologist with over 12 years of experience in the pharmaceutical industry, I bring expertise in medical affairs strategy development and execution. My proven track record includes leading global medical initiatives, such as designing impactful medical educational programs and managing real-world evidence registries. With a keen focus on stakeholder engagement and portfolio optimization, I excel in co-developing evidence-generation plans, medical education strategies, and innovative communication initiatives. My proficiency in financial tracking ensures the timely and cost-effective execution of medical activities, while my ability to represent medical affairs internally and externally underscores my capacity to advocate for prioritized portfolios effectively. Moreover, my dedication to patient-centric care programs and compliance expertise positions me well to ensure the successful implementation of patient access initiatives across all brands within the Global Medical Affairs realm. Overall, my leadership, collaborative approach, and proactive mindset make me a valuable asset for advancing organizational objectives in this role.

Overview

19
19
years of professional experience

Work History

Global Medical Lead (Global Director)

Sanofi
01.2022 - Current
  • Crafted and implemented a robust stakeholder engagement strategy, fostering collaborations with KOLs, medical societies, and patient advocacy groups
  • Led the development of the hemophilia portfolio strategy and devised novel medical strategies for ALPROLIX, aligning seamlessly with a portfolio approach
  • Played a pivotal role in the successful market launch of ALTUVIIIO, ensuring coordinated introduction and advancing mission
  • Established best-practice Integrated KOLs and Stakeholder engagement plan adopted company-wide within the Rare Blood Disorders business unit
  • Designed, created, and coordinated hemophilia education across portfolio events, developing educational agenda and implementation
  • Fostered collaborative creation and execution of strategies, aligning various internal functions

Global Medical Lead (Global Director)

Shire / Takeda
Zug/Zurich
01.2018 - 12.2021
  • Led management of AHEAD, the premier global Hemophilia A registry, enhancing real-world evidence and global data
  • Coordinated symposia at global congresses, contributing to faculty selection, agenda/content development, and speaker briefing/execution
  • Played a key role in developing and implementing hemophilia A portfolio medical plans
  • Directed global medical strategy for hemophilia franchise, developing scientific narrative and tactical-strategic plan for insights collection, data communication, and evidence generation
  • Introduced a comprehensive joint health educational program for hemophilia patients
  • Provided active support for ADVATE and ADYNOVI lifecycle management, expanding labels through comprehensive medical/scientific publications
  • Engaged in consultancy and advisory boards with Global KOLs

Medical Manager

Novo Nordisk
Mexico
01.2012 - 12.2017
  • Managed a team of Medical Science Liaisons (MSLs), ensuring effective collaboration and communication within the team and with external stakeholders
  • Led impactful consultancy and advisory boards, fostering dialogue with national medical leaders and payers
  • Created high-quality symposia content and maintained strong cross-functional partnerships with senior management and various departments
  • Enhanced NovoSeven's lifecycle management, expanding its label to cover other bleeding disorders
  • Coordinated successful educational events in hemophilia nationwide
  • Managed the smooth launch of NOVOEIGHT in Mexico and Colombia, executing strategic plans

Hematologist

01.2006 - 12.2012
  • Enriched professional capabilities by gaining six years of clinical experience in General Hematology and Hemotherapy
  • Provided quality leadership and supervision to the Clinic of Hemostasis and Thrombosis Disorders in attaining targeted objectives
  • Managed and mentored trainees, ensuring their development and adherence to clinical best practices
  • Co-authored National Guidelines of Hemophilia
  • Assisted in the Anemia Clinic, addressing various hematological conditions

Education

M.D. - Oncohematology and Hemotherapy

Universidad Nacional Autonoma De Mexico

M.D. - Internal Medicine

Universidad Nacional Autonoma de Mexico

M.D. - General Medicine and Surgery

Benemerita Universidad Autonoma de Puebla

Skills

Global medical experience in hematology and gene therapy

Strategic global medical planning & execution

External stakeholder engagement global strategy

Portfolio medical strategy

Lifecycle management

Programs & projects management

Key relationship development

Cross-functional stakeholder collaboration

People management and team leadership

Professional experience

Languageproficiencies

  • Spanish (Native)
  • English (Business proficiency)
  • German (Basic)

Personal Information

  • Date of Birth: 10/16/1975
  • Nationality: Spain

Awards

Excellent Performance Global Medical Affairs, Novo Nordisk, 2015

Accomplishments

Excellent Performance Global Medical Affairs, Novo Nordisk, 2015

Language Proficiencies

Spanish
First Language
English
Proficient (C2)
C2
German
Elementary (A2)
A2

Swiss C Permit

MA1767053

Timeline

Global Medical Lead (Global Director)

Sanofi
01.2022 - Current

Global Medical Lead (Global Director)

Shire / Takeda
01.2018 - 12.2021

Medical Manager

Novo Nordisk
01.2012 - 12.2017

Hematologist

01.2006 - 12.2012

M.D. - Oncohematology and Hemotherapy

Universidad Nacional Autonoma De Mexico

M.D. - Internal Medicine

Universidad Nacional Autonoma de Mexico

M.D. - General Medicine and Surgery

Benemerita Universidad Autonoma de Puebla
Alejandro Fernandez